Prevalence of Asthma Characteristics in COPD Patients in a Dutch Well-Established Asthma/COPD Service for Primary Care

References

• Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2019.
   Google Scholar
• López-CamposJL, Ruiz-RamosM, SorianoJB. Mortality trends in chronic obstructive pulmonary disease in Europe, 1994–2010: a joinpoint regression analysis. Lancet Respir Med. 2014;2(1):54–62. doi:10.1016/S2213-2600(13)70232-724461902
   PubMed Web of Science ®Google Scholar
• LopezAD, ShibuyaK, RaoC, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27(2):397–412. doi:10.1183/09031936.06.0002580516452599
   PubMed Web of Science ®Google Scholar
• European Respiratory Society. Chronic Obstructive Pulmonary Disease; White Book Chapter 13.
   Google Scholar
• PoosMJJC, NielenMMJ Prevalentie en nieuwe gevallen van COPD. 2019 Available from: https://www.volksgezondheidenzorg.info/onderwerp/copd/cijfers-context/huidige-situatie#!node-prevalentie-en-nieuwe-gevallen-van-copd. Accessed 174 2019.
   Google Scholar
• Snoeck-StrobandJB, SchermerTRJ, Van SchayckCP, et al. NHG-Standaard COPD (Derde Herziening). 2015.
   Google Scholar
• Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention; 2016.
   Google Scholar
• PriceDB, WestD, Gruffydd-JonesK, et al. Management of COPD in the UK primary-care setting: an analysis of real life prescribing patterns. Int J Chronic Obstruct Pulmon Dis. 2014;9:889–905. doi:10.2147/COPD.S62750
   PubMed Web of Science ®Google Scholar
• BloomCI, ElkinSL, QuintJK. Changes in COPD inhaler prescriptions in the united kingdom, 2000 to 2016. Int J COPD. 2019;14:279–287. doi:10.2147/COPD.S190086
   Google Scholar
• Geraets I, SchermerT, KocksJWH, Akkermans R, Bischoff E, van den Bemt L. Primary care cohort study in the sequence of diagnosing chronic respiratory diseases and prescribing inhaled corticosteroids. NPJ Prim Care Respir Med. 2018;28:3–4. doi:10.1038/s41533-018-0071-029362452
   PubMed Web of Science ®Google Scholar
• LambooijA, Metz deJ, EssinkR, et al. Medicatie bij Astma en COPD: voorschrijvenen gebruik in de eerste lijn. 2016.
   Google Scholar
• SulkuJ, JansonC, MelhusH, et al. A cross-sectional study assessing appropriateness of inhaled corticosteroid treatment in primary and secondary care patients with COPD in Sweden. Int J COPD. 2019;14:2451–2460. doi:10.2147/COPD.S218747
   Google Scholar
• LipsonDA, BarnacleH, BirkR, et al. FULFIL trial: once-daily triple therapy for patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;196(4):438–446. doi:10.1164/rccm.201703-0449OC28375647
   PubMed Web of Science ®Google Scholar
• LipsonDA, BarnhartF, BrealeyN, et al. Once-daily single-inhaler triple versus dual therapy in patients with COPD. N Engl J Med. 2018;378:1671–1680. doi:10.1056/NEJMoa171390129668352
   PubMed Web of Science ®Google Scholar
• PapiA, VestboJ, FabbriL, et al. Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial. Lancet. 2018;391:1076–1084. doi:10.1016/S0140-6736(18)30206-X29429593
   PubMed Web of Science ®Google Scholar
• KaplanAG, Roman-RodriguezM, PriceDB, TsiligianniI. Appropriate use and withdrawal of inhaled corticosteroids in patients with COPD. 2014 NPJ Prim Care Respir Med.
   PubMed Web of Science ®Google Scholar
• YawnBP, LiY, TianH, ZhangJ, ArconaS, KahlerKH. Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis. Int J COPD. 2013;8:295–304. doi:10.2147/COPD.S42366
   Google Scholar
• SuissaS, PatenaudeV, LapiF, ErnstP. Inhaled corticosteroids in COPD and the risk of serious pneumonia. Thorax. 2013;68(11):1029–1036. doi:10.1136/thoraxjnl-2012-20287224130228
   PubMed Web of Science ®Google Scholar
• AjmeraM, ShenC, SambamoorthiU. Concomitant medication use and new-onset diabetes among medicaid beneficiaries with chronic obstructive pulmonary disease. Popul Health Manag. 2017;20:224–232. doi:10.1089/pop.2016.004727689453
   PubMed Web of Science ®Google Scholar
• SuissaS, KezouhA, ErnstP. Inhaled corticosteroids and the risks of diabetes onset and progression. Am J Med. 2010;123(11):1001–1006. doi:10.1016/j.amjmed.2010.06.01920870201
   PubMed Web of Science ®Google Scholar
• PriceDB, RussellR, MaresR, et al. Metabolic effects associated with ICS in patients with COPD and comorbid type 2 diabetes: a historical matched cohort study. PLoS One. 2016;11(9):1–17. doi:10.1371/journal.pone.0162903
   Web of Science ®Google Scholar
• LokeYK, CavallazziR, SinghS. Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies. Thorax. 2011;66(8):699–708. doi:10.1136/thx.2011.16002821602540
   PubMed Web of Science ®Google Scholar
• SuissaS, CoulombeJ, ErnstP. Discontinuation of inhaled corticosteroids in COPD and the risk reduction of pneumonia. Chest. 2015;148(5):1177–1183. doi:10.1378/chest.15-062726110239
   PubMed Web of Science ®Google Scholar
• AgustiA, FabbriLM, SinghD. et al. Inhaled corticosteroids in COPD: friend or foe? Eur Respir J;2018 1801219. doi:10.1183/13993003.01219-201830190269
   PubMed Web of Science ®Google Scholar
• KaplanAG, FabbriLM, SinghD. Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice. Int J COPD. 2015;10:2535–2548. doi:10.2147/COPD.S93321
   Google Scholar
• WatzH, TetzlaffK, WoutersEFM, et al. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. Lancet Respir Med. 2016;4(5):390–398. doi:10.1016/S2213-2600(16)00100-427066739
   PubMed Web of Science ®Google Scholar
• BafadhelM, PetersonS, De BlasMA, et al. Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials. Lancet Respir. Med. 2018;6(2):117–126. doi:10.1016/S2213-2600(18)30006-729331313
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Diagnosis of Diseases of Chronic Airflow Limitation: Asthma, COPD and Asthma - COPD Overlap Syndrome (ACOS); 2015.
   Google Scholar
• LeungJM, SinDD. Inhaled corticosteroids in COPD: the final verdict is …. Eur Respir J. 2018;52:1801940. doi:10.1183/13993003.01940-201830545961
   PubMed Web of Science ®Google Scholar
• MettingEI, RiemersmaRA, KocksJWH, Piersma-WichersMG, SandermanR, Van Der MolenT. Feasibility and effectiveness of an Asthma/COPD service for primary care: a cross-sectional baseline description and longitudinal results. NPJ Prim Care Respir Med. 2015;25(1):1–7. doi:10.1038/npjpcrm.2014.101
   Web of Science ®Google Scholar
• von ElmE, AltmanDG, EggerM, PocockSJ, GøtzschePC, VandenbrouckeJP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12:1495–1499. doi:10.1016/j.ijsu.2014.07.01325046131
   PubMed Web of Science ®Google Scholar
• van der MolenT, WillemseBWM, SchokkerS, Ten HackenNHT, PostmaDS, JuniperEF. Development, validity and responsiveness of the clinical COPD questionnaire. Health Qual Life Outcomes. 2003;1(1):1–10. doi:10.1186/1477-7525-1-1312605709
   PubMedGoogle Scholar
• JuniperEF, BousquetJ, AbetzL, BatemanED. Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control Questionnaire. Respir. Med. 2006;100(4):616–621. doi:10.1016/j.rmed.2005.08.01216226443
   PubMed Web of Science ®Google Scholar
• SilvaGE, SherrillDL, GuerraS, BarbeeRA. Asthma as a risk factor for COPD in a longitudinal study. Chest. 2004;126(1):59–65. doi:10.1378/chest.126.1.5915249443
   PubMed Web of Science ®Google Scholar
• TsiligianniI, MettingE, Van Der MolenT, ChavannesN, KocksJWH. Morning and night symptoms in primary care COPD patients: a cross-sectional and longitudinal study. An UNLOCK study from the IPCRG. NPJ Prim Care Respir Med. 2016;26(1):1–8. doi:10.1038/npjpcrm.2016.40
   Web of Science ®Google Scholar
• AlbertP, AgustiA, EdwardsL, et al. Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease. Thorax. 2012;67(8):701–708. doi:10.1136/thoraxjnl-2011-20145822696176
   PubMed Web of Science ®Google Scholar
• De JongC, Van BovenJ, SchermerT, et al. Why prescribe ICS to Dutch COPD patients in primary care, and when and how to stop. Data from focus groups with patients and health care providers. Gen Pract Prim Care. 2018;52:PA917.
   Web of Science ®Google Scholar
• AgustiA, BelE, ThomasM, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur. Respir. J. 2016;47(2):410–419. doi:10.1183/13993003.01359-201526828055
   PubMed Web of Science ®Google Scholar
• JenkinsC, FitzGeraldJM, MartinezFJ, et al. Diagnosis and management of asthma, COPD and asthma‐COPD overlap among primary care physicians and respiratory/allergy specialists: a global survey. Clin. Respir. J. 2019;13(6):355–367. doi:10.1111/crj.1301630825365
   PubMed Web of Science ®Google Scholar
• LucasAE, SmeenkFJ, van den BorneBE, SmeeleIJ, van SchayckOC. Diagnostic assessments of spirometry and medical history data by respiratory specialists supporting primary care: are they reliable? Prim. Care Respir. J. 2009;18(3):177–184. doi:10.3132/pcrj.2009.0000219139795
   PubMedGoogle Scholar
• LucasA, SmeenkFJWM, BrouwerT, SmeeleI, BrouwerT. The validity of diagnostic support of an asthma/COPD service in primary care. Br J Gen Pract. 2007;57(544):892–896. doi:10.3399/09601640778231788317976290
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Pocket Guide for Asthma Management and Prevention. Global Initiative for Asthma; 2019.
   Google Scholar
• SmeeleI, BarnhoornMJM, BroekhuizenBDL, et al. NHG-Standaard Astma Bij Volwassenen (Derde Herziening). 2015.
   Google Scholar